Detailed answers about BFS IMIDAZOLINE 1 LLP, including incorporation, status, business activity, and accounts information.
When was BFS IMIDAZOLINE 1 LLP founded?
BFS IMIDAZOLINE 1 LLP was officially incorporated on 10 February 2016 and is registered under company number SO305600. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is BFS IMIDAZOLINE 1 LLP?
Limited Liability Partnership. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of BFS IMIDAZOLINE 1 LLP?
BFS IMIDAZOLINE 1 LLP's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What is BFS IMIDAZOLINE 1 LLP's registered address?
The registered office address of BFS IMIDAZOLINE 1 LLP is C/O PHILIP BALD ACCOUNTANCY, 3B ORMISTON TERRACE, EDINBURGH, EH12 7SJ. This is the official address filed with Companies House for legal and statutory correspondence.
Is BFS IMIDAZOLINE 1 LLP financially stable?
The most recent accounts for BFS IMIDAZOLINE 1 LLP were made up to 31 March 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 December 2026.